NHS approves two cannabis-based medicines for children suffering from epilepsy

NHS approves two cannabis-based medicines for children suffering from epilepsy

NHS England has approved two cannabis-based medicines used for alleviating the symptoms of epilepsy and multiple sclerosis.  The NHS follows the new guidelines issued by the drug advisory body NICE, which looks at products for several conditions. Although charities seem to have welcomed the move by NHS, some campaigners who have been struggling for access to the drugs say that this does not go far enough. Both cannabis-based medicines are grown and developed in the UK. Doctors will now be able to prescribe Epidyolex for children who suffer from two severe forms of epilepsy- Dravet syndrome and Lennox Gastaut syndrome- which tend to cause multiple seizures a day. The clinical trials conducted on Epidyolex have shown that it contains cannabidiol or CBD, which could possibly reduce the number of seizures by up to 40% in some cases. The estimated number of people suffering from Dravet is 3,000, whereas it is 5,000 for people with Lennox Gastaut syndrome in England. Despite Epiyolex being approved for use in Europe back in September, NICE initially said that the product was not worth the money. It costs between £5,000 and £10,000 per patient each year, but GW Pharmaceuticals, the manufacturer of Epidyolex has agreed…

Excerpt only …
READ MORE BELOW
Source : Cannabis Radar
Link to original : NHS approves two cannabis-based medicines for children suffering from epilepsy
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.